#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Colorectal cancer Dementia Alzheimer's type Ovarian cancer Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Hypereosinophilic syndrome Hereditary hypophosphataemic rickets Follicular lymphoma stage III Rett syndrome Erythema multiforme Glomerulonephritis membranoproliferative Oesophageal squamous cell carcinoma stage II Mitochondrial myopathy Isodicentric chromosome 15 syndrome Haemophagocytic lymphohistiocytosis Small intestine leiomyosarcoma Metachromatic leukodystrophy Immunoglobulin G4 related disease Oesophageal adenocarcinoma Transferrin decreased More trials…

    Learn about Rare Diseases

    Rett syndrome – Treatment Hairy cell leukaemia recurrent – Trials in Disease Antithrombin III deficiency – Treatment Wolfram syndrome – Basic Information Shprintzen-Goldberg syndrome – Treatment Primary mediastinal large B-cell lymphoma – Life with Disease Hereditary angioedema – Treatment Gaucher’s disease type III – Life with Disease Haemophilia B without inhibitors – Life with Disease Optic glioma – Trials in Disease More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    ANXV [18F]Fluoro-Peg-Folate Ertugliflozin Vanglusagene Ensiparvovec Cilazapril VENT-03 Phenol, Liquefied Ieramilimab Tipiracil Hydrochloride Rintatolimod Methotrexate Sodium L-Arginine Hydrochloride Sar441566 Gallium (68Ga) Chloride Wt1 Lamp Mrna Dc Azetukalner NORGESTIMATE Flutamide Satoreotide Tetraxetan Olaparib More therapies…

    Learn about Your Condition

    Orthostatic hypotension Pulmonary sarcoidosis Thrombosis Porphyria non-acute Essential hypertension Postpartum haemorrhage Cervical dysplasia Myasthenia gravis Acromegaly Juvenile idiopathic arthritis End stage renal disease Pulmonary tuberculosis Mucous membrane pemphigoid Vascular dementia Hairy cell leukaemia More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Osteoporosis postmenopausal

  • Study of Everolimus and Resistance Training to Improve Bone Formation in Healthy Postmenopausal Women

    Recruiting

    2 1 1
    Investigated Diseases:
    • Osteoporosis postmenopausal
    Investigated Drugs:
    • Everolimus
    • Placebo
    Denmark

  • Study on Everolimus and Exercise to Prevent Bone Loss in Healthy Postmenopausal Women

    Recruiting

    2 1 1 1
    Investigated Diseases:
    • Osteoporosis postmenopausal
    Investigated Drugs:
    • Everolimus
    Denmark

  • Study on Zoledronic Acid Use After Stopping Denosumab in Women with Postmenopausal Osteoporosis

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Osteoporosis postmenopausal
    Investigated Drugs:
    • Zoledronic Acid
    France

  • Study of Denosumab Effects on Muscle Strength and Insulin Sensitivity in Patients with Postmenopausal Osteoporosis and Diabetes Mellitus

    Recruiting

    3 1 1
    Investigated Diseases:
    • Osteoporosis postmenopausal
    • Diabetes mellitus
    Investigated Drugs:
    • Denosumab
    • Saline
    Denmark

  • Comparing the effect of romosozumab and denosumab on coronary artery damage in women with postmenopausal osteoporosis

    Not yet recruiting

    3 1 1 1
    Investigated Drugs:
    • Romosozumab
    • Denosumab
    Italy

  • Study on the Effects of BP16 and Denosumab in Women with Post-Menopausal Osteoporosis

    Not yet recruiting

    3 1 1 1
    Investigated Diseases:
    • Osteoporosis postmenopausal
    Investigated Drugs:
    • Calcium Lactate Gluconate
    • Denosumab
    • Ascorbic Acid
    Bulgaria Estonia Hungary Latvia Poland Slovakia
1 2
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!